Published Erratum
doi: 10.1038/s41586-020-03108-4.
Publisher Correction: A vaccine targeting the RBD of the S protein of SARS-CoV-2 induces protective immunity
Jingyun Yang #
1
, Wei Wang #
1
, Zimin Chen #
1
, Shuaiyao Lu #
2
, Fanli Yang #
1
, Zhenfei Bi #
1
, Linlin Bao #
3
, Fei Mo
1
, Xue Li
1
, Yong Huang
1
, Weiqi Hong
1
, Yun Yang
2
, Yuan Zhao
2
, Fei Ye
1
, Sheng Lin
1
, Wei Deng
3
, Hua Chen
1
, Hong Lei
1
, Ziqi Zhang
1
, Min Luo
1
, Hong Gao
3
, Yue Zheng
1
, Yanqiu Gong
1
, Xiaohua Jiang
1
, Yanfeng Xu
3
, Qi Lv
3
, Dan Li
1
, Manni Wang
1
, Fengdi Li
3
, Shunyi Wang
3
, Guanpeng Wang
3
, Pin Yu
3
, Yajin Qu
3
, Li Yang
1
, Hongxin Deng
1
, Aiping Tong
1
, Jiong Li
1
, Zhenling Wang
1
, Jinliang Yang
1
, Guobo Shen
1
, Zhiwei Zhao
1
, Yuhua Li
4
, Jingwen Luo
1
, Hongqi Liu
2
, Wenhai Yu
2
, Mengli Yang
2
, Jingwen Xu
2
, Junbin Wang
2
, Haiyan Li
2
, Haixuan Wang
2
, Dexuan Kuang
2
, Panpan Lin
1
, Zhengtao Hu
5
, Wei Guo
5
, Wei Cheng
1
, Yanlin He
5
, Xiangrong Song
1
, Chong Chen
1
, Zhihong Xue
1
, Shaohua Yao
1
, Lu Chen
1
, Xuelei Ma
1
, Siyuan Chen
1
, Maling Gou
1
, Weijin Huang
4
, Youchun Wang
4
, Changfa Fan
4
, Zhixin Tian
6
, Ming Shi
7
, Fu-Sheng Wang
7
, Lunzhi Dai
1
, Min Wu
1
, Gen Li
8
, Guangyu Wang
9
, Yong Peng
1
, Zhiyong Qian
1
, Canhua Huang
1
, Johnson Yiu-Nam Lau
10
, Zhenglin Yang
11
, Yuquan Wei
1
, Xiaobo Cen
1
5
, Xiaozhong Peng
2
12
, Chuan Qin
3
, Kang Zhang
13
, Guangwen Lu
14
15
, Xiawei Wei
16
Affiliations
Affiliations
- 1 Laboratory of Aging Research and Cancer Drug Target, State Key Laboratory of Biotherapy and Cancer Center, National Clinical Research Center for Geriatrics, West China Hospital, Sichuan University, Chengdu, China.
- 2 National Kunming High-level Biosafety Primate Research Center, Institute of Medical Biology, Chinese Academy of Medical Sciences and Peking Union Medical College, Yunnan, China.
- 3 Key Laboratory of Human Disease Comparative Medicine, Chinese Ministry of Health, Beijing Key Laboratory for Animal Models of Emerging and Remerging Infectious Diseases, Institute of Laboratory Animal Science, Chinese Academy of Medical Sciences and Comparative Medicine Center, Peking Union Medical College, Beijing, China.
- 4 National Institutes for Food and Drug Control (NIFDC), Beijing, China.
- 5 National Chengdu Center for Safety Evaluation of Drugs, State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University, Collaborative Innovation Center for Biotherapy, Chengdu, China.
- 6 Shanghai Key Laboratory of Chemical Assessment and Sustainability, School of Chemical Science & Engineering, Tongji University, Shanghai, China.
- 7 Treatment and Research Center for Infectious Diseases, The Fifth Medical Center of PLA General Hospital, National Clinical Research Center for Infectious Diseases, Beijing, China.
- 8 Center for Biomedicine and Innovations, Faculty of Medicine, Macau University of Science and Technology, Macau, China.
- 9 Department of Computer Science and Technology, Tsinghua University, Beijing, China.
- 10 Department of Applied Biology and Chemical Technology, Hong Kong Polytechnic University, Hong Kong, China.
- 11 Sichuan Provincial Key Laboratory for Human Disease Gene Study and Institute of Laboratory Medicine, Sichuan Provincial People's Hospital, University of Electronic Science and Technology of China, Chengdu, China.
- 12 State Key Laboratory of Medical Molecular Biology, Chinese Academy of Medical Sciences, School of Basic Medicine, Peking Union Medical College, Beijing, China.
- 13 Center for Biomedicine and Innovations, Faculty of Medicine, Macau University of Science and Technology, Macau, China. kang.zhang@gmail.com.
- 14 Laboratory of Aging Research and Cancer Drug Target, State Key Laboratory of Biotherapy and Cancer Center, National Clinical Research Center for Geriatrics, West China Hospital, Sichuan University, Chengdu, China. lugw@scu.edu.cn.
- 15 Emergency Department, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, China. lugw@scu.edu.cn.
- 16 Laboratory of Aging Research and Cancer Drug Target, State Key Laboratory of Biotherapy and Cancer Center, National Clinical Research Center for Geriatrics, West China Hospital, Sichuan University, Chengdu, China. xiaweiwei@scu.edu.cn.
# Contributed equally.
- PMID: 33469221
- DOI: 10.1038/s41586-020-03108-4
Item in Clipboard
Published Erratum
Publisher Correction: A vaccine targeting the RBD of the S protein of SARS-CoV-2 induces protective immunity
Jingyun Yang et al.
Nature.
2021 Feb.
Display options
Format
doi: 10.1038/s41586-020-03108-4.
Authors
Jingyun Yang #
1
, Wei Wang #
1
, Zimin Chen #
1
, Shuaiyao Lu #
2
, Fanli Yang #
1
, Zhenfei Bi #
1
, Linlin Bao #
3
, Fei Mo
1
, Xue Li
1
, Yong Huang
1
, Weiqi Hong
1
, Yun Yang
2
, Yuan Zhao
2
, Fei Ye
1
, Sheng Lin
1
, Wei Deng
3
, Hua Chen
1
, Hong Lei
1
, Ziqi Zhang
1
, Min Luo
1
, Hong Gao
3
, Yue Zheng
1
, Yanqiu Gong
1
, Xiaohua Jiang
1
, Yanfeng Xu
3
, Qi Lv
3
, Dan Li
1
, Manni Wang
1
, Fengdi Li
3
, Shunyi Wang
3
, Guanpeng Wang
3
, Pin Yu
3
, Yajin Qu
3
, Li Yang
1
, Hongxin Deng
1
, Aiping Tong
1
, Jiong Li
1
, Zhenling Wang
1
, Jinliang Yang
1
, Guobo Shen
1
, Zhiwei Zhao
1
, Yuhua Li
4
, Jingwen Luo
1
, Hongqi Liu
2
, Wenhai Yu
2
, Mengli Yang
2
, Jingwen Xu
2
, Junbin Wang
2
, Haiyan Li
2
, Haixuan Wang
2
, Dexuan Kuang
2
, Panpan Lin
1
, Zhengtao Hu
5
, Wei Guo
5
, Wei Cheng
1
, Yanlin He
5
, Xiangrong Song
1
, Chong Chen
1
, Zhihong Xue
1
, Shaohua Yao
1
, Lu Chen
1
, Xuelei Ma
1
, Siyuan Chen
1
, Maling Gou
1
, Weijin Huang
4
, Youchun Wang
4
, Changfa Fan
4
, Zhixin Tian
6
, Ming Shi
7
, Fu-Sheng Wang
7
, Lunzhi Dai
1
, Min Wu
1
, Gen Li
8
, Guangyu Wang
9
, Yong Peng
1
, Zhiyong Qian
1
, Canhua Huang
1
, Johnson Yiu-Nam Lau
10
, Zhenglin Yang
11
, Yuquan Wei
1
, Xiaobo Cen
1
5
, Xiaozhong Peng
2
12
, Chuan Qin
3
, Kang Zhang
13
, Guangwen Lu
14
15
, Xiawei Wei
16
Affiliations
- 1 Laboratory of Aging Research and Cancer Drug Target, State Key Laboratory of Biotherapy and Cancer Center, National Clinical Research Center for Geriatrics, West China Hospital, Sichuan University, Chengdu, China.
- 2 National Kunming High-level Biosafety Primate Research Center, Institute of Medical Biology, Chinese Academy of Medical Sciences and Peking Union Medical College, Yunnan, China.
- 3 Key Laboratory of Human Disease Comparative Medicine, Chinese Ministry of Health, Beijing Key Laboratory for Animal Models of Emerging and Remerging Infectious Diseases, Institute of Laboratory Animal Science, Chinese Academy of Medical Sciences and Comparative Medicine Center, Peking Union Medical College, Beijing, China.
- 4 National Institutes for Food and Drug Control (NIFDC), Beijing, China.
- 5 National Chengdu Center for Safety Evaluation of Drugs, State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University, Collaborative Innovation Center for Biotherapy, Chengdu, China.
- 6 Shanghai Key Laboratory of Chemical Assessment and Sustainability, School of Chemical Science & Engineering, Tongji University, Shanghai, China.
- 7 Treatment and Research Center for Infectious Diseases, The Fifth Medical Center of PLA General Hospital, National Clinical Research Center for Infectious Diseases, Beijing, China.
- 8 Center for Biomedicine and Innovations, Faculty of Medicine, Macau University of Science and Technology, Macau, China.
- 9 Department of Computer Science and Technology, Tsinghua University, Beijing, China.
- 10 Department of Applied Biology and Chemical Technology, Hong Kong Polytechnic University, Hong Kong, China.
- 11 Sichuan Provincial Key Laboratory for Human Disease Gene Study and Institute of Laboratory Medicine, Sichuan Provincial People's Hospital, University of Electronic Science and Technology of China, Chengdu, China.
- 12 State Key Laboratory of Medical Molecular Biology, Chinese Academy of Medical Sciences, School of Basic Medicine, Peking Union Medical College, Beijing, China.
- 13 Center for Biomedicine and Innovations, Faculty of Medicine, Macau University of Science and Technology, Macau, China. kang.zhang@gmail.com.
- 14 Laboratory of Aging Research and Cancer Drug Target, State Key Laboratory of Biotherapy and Cancer Center, National Clinical Research Center for Geriatrics, West China Hospital, Sichuan University, Chengdu, China. lugw@scu.edu.cn.
- 15 Emergency Department, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, China. lugw@scu.edu.cn.
- 16 Laboratory of Aging Research and Cancer Drug Target, State Key Laboratory of Biotherapy and Cancer Center, National Clinical Research Center for Geriatrics, West China Hospital, Sichuan University, Chengdu, China. xiaweiwei@scu.edu.cn.
# Contributed equally.
- PMID: 33469221
- DOI: 10.1038/s41586-020-03108-4
Item in Clipboard
Display options
Format
No abstract available
Erratum for
-
A vaccine targeting the RBD of the S protein of SARS-CoV-2 induces protective immunity.Yang J, Wang W, Chen Z, Lu S, Yang F, Bi Z, Bao L, Mo F, Li X, Huang Y, Hong W, Yang Y, Zhao Y, Ye F, Lin S, Deng W, Chen H, Lei H, Zhang Z, Luo M, Gao H, Zheng Y, Gong Y, Jiang X, Xu Y, Lv Q, Li D, Wang M, Li F, Wang S, Wang G, Yu P, Qu Y, Yang L, Deng H, Tong A, Li J, Wang Z, Yang J, Shen G, Zhao Z, Li Y, Luo J, Liu H, Yu W, Yang M, Xu J, Wang J, Li H, Wang H, Kuang D, Lin P, Hu Z, Guo W, Cheng W, He Y, Song X, Chen C, Xue Z, Yao S, Chen L, Ma X, Chen S, Gou M, Huang W, Wang Y, Fan C, Tian Z, Shi M, Wang FS, Dai L, Wu M, Li G, Wang G, Peng Y, Qian Z, Huang C, Lau JY, Yang Z, Wei Y, Cen X, Peng X, Qin C, Zhang K, Lu G, Wei X. Yang J, et al. Nature. 2020 Oct;586(7830):572-577. doi: 10.1038/s41586-020-2599-8. Epub 2020 Jul 29. Nature. 2020. PMID: 32726802
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous
